αiI-spectrin breakdown products (SBDPs): Diagnosis and outcome in severe traumatic brain injury patients

Journal of Neurotrauma

Volumn 27, Issue 7, 2010, Pages 1203-1213

  Mondello, Stefania ^a   Robicsek, Steven A ^b   Gabrielli, Andrea ^b   Brophy, Gretchen M ^c   Papa, Linda ^d   Tepas, Joseph ^a   Robertson, Claudia ^e   Buki, Andras ^f   Scharf, Dancia ^g   Jixiang, Mo ^g   Akinyi, Linnet ^g   Muller, Uwe ^g   Wang, Kevin K W ^a   Hayes, Ronald L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d ORLANDO REGIONAL MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PÉCS   (Hungary)

^g BANYAN BIOMARKERS INC   (United States)

Author keywords

biomarkers; brain injury; diagnostic; neuronal death; outcome; spectrin breakdown products

Indexed keywords

ALPHAII SPECTRIN BREAKDOWN PRODUCT; PROTEIN SBDP120; PROTEIN SBDP145; SPECTRIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANASTOMOSIS; ARTICLE; BRAIN DAMAGE; CEREBROSPINAL FLUID DRAINAGE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HUMAN; INJURY SEVERITY; MALE; MORTALITY; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ISOFORMS; SEVERITY OF ILLNESS INDEX; SPECTRIN; SURVIVAL RATE; YOUNG ADULT;

EID: 77955077424     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1278     Document Type: Article

References (84)

1. Ai, J., Liu, E., Wang, J., Chen, Y., Yu, J., and Baker, A.J. (2007). Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J. Neurotrauma 24, 960-978.
2. Anderson, R.E.H.L., Nilsson, O., Dijai-Merzoug, R., and Setter-gen, G. (2001). High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1272-1273.
3. Aurell, A., Rosengren, L.E., Karlsson, B., Olsson, J.E., Zborni-kowa, V., and Haglid, K.G. (1991). Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 22, 1254-1258.
4. Balestreri, M., Czosnyka, M., Hutchinson, P., Steiner, L.A., Hiler, M., Smielewski, P., and Pickard, J.D. (2004). Predictive value of Glasgow Coma Scale after brain trauma: change in trend over the past ten years. J. Neurol. Neurosurg. Psychiatry 75, 161-162.
5. Beer, R., Franz, G., Krajewski, S., Pike, B.R., Hayes, R.L., Reed, J.C., Wang, K.K., Klimmer, C., Schmutzhard, E., Poewe, W., and Kampfl, A. (2000). Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J. Neurochem. 75, 1264-1273.
6. Belanger, H.G., Vanderploeg, R.D., Curtiss, G., and Warden, D.L. (2007). Recent neuroimaging techniques in mild traumatic brain injury. J. Neuropsychiatry Clin. Neurosci. 19, 5-20. (Pubitemid 46294440)
7. Blennow, M., Rosengren, L., Jonsson, S., Forssberg, H., Katz-Salamon, M., Hagberg, H., Hesser, U., and Lagercrantz, H. (1996). Glial fibrillary acidic protein is increased in the cere-brospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr. 85, 485-489.
8. Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A., and McLean, A.J. (1994). Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344, 1055-1056.
9. Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A., and McLean, A.J. (1995). Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J. Neurotrauma 12, 565-572.
10. Brenner, D.J., and Hall, E.J. (2007). Computed tomography\an increasing source of radiation exposure. N. Engl. J. Med. 22, 2277-2284.
11. Brophy, G.M., Pineda, J.A., Papa, L., Lewis, S.B., Valadka, A.B., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Tepas, J.J. 3rd, Gabrielli, A., Robicsek, S., Wang, K.K., Robertson, C.S., and Hayes, R.L. (2009). alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 264, 471-479.
12. Bruns, J., Jr., and Hauser, W.A. (2009). The epidemiology of traumatic brain injury: a review. Epilepsia 44, (Suppl. 10), 2-10.
13. Bullard, T., Papa, L., Wegst, A., and Falk, J. (2007). Estimating the cumulative risk of ionizing radiation exposure from diagnostic testing in an emergency department population: What do we really know? Acad. Emerg. Med. 14, 5 (Suppl. 1).
14. Cardali, S., and Maugeri, R. (2006). Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 50, 25-31.
15. Choi, S.C., and Barnes, T.Y. (1996). Predicting outcome in the head-injured patient, in: Neurotrauma, R.K. Narayan, E. Wilberger, and Povlishock, J.T. (eds), McGraw Hill: New York, pps. 779-792.
16. Cole, T.B. (2004). Global road safety crisis remedy sought: 1.2 million killed, 50 million injured annually. JAMA 291, 531-532.
17. Eng, L.F. (1980). The glial fibrillary acidic protein, in: Proteins of the Nervous System, R.A. Bradshaw, and D.M. Schneider (eds), Raven Press: New York, pps. 85-117.
18. Eng, L.F., Vanderhaeghen, J.J., Bignami, A., and Gersti, B. (1971). An acidic protein isolated from fibrous astrocytes. Brain Res. 28, 351-354.
19. Farkas, O., Polgár, B., Szekeres-Barthó, J., Dóczi, T., Povlishock, J.T., and Büki, A. (2005). Spectrin breakdown products in the cerebrospinal fluid in severe head injury\preliminary observations. Acta Neurochir. Wien. 1478, 855-861.
20. Gennarelli, T.A. (1996). The spectrum of traumatic axonal injury. Neuropathol. Appl. Neurobiol. 22, 509-513.
21. Gentleman, S.M., Nash, M.J., Sweeting, C.J., Graham, D.I., and Roberts, G.W. (1993). ß-Amyloid precursor protein/3-APP as a marker for axonal injury after head injury. Neurosci. Lett. 160, 139-144.
22. Ghajar, J. (2000). Traumatic brain injury. Lancet 356, 923-929.
23. Graham, D.I., and Gennarelli, T.A. (1997). Trauma, in: Greenfields Neuropathology, 6th ed. Arnold: London, pps. 197-262.
24. Hall, E.D., Sullivan, P.G., Gibson, T.R., Pavel, K.M., Thompson, B.M., and Scheff, S.W. (2005). Spatial and temporal characteristics of neurodegeneration after controlled cortical impact in mice: more than a focal brain injury. J. Neurotrauma 22, 252-265.
25. Hukkelhoven, C.W., Steyerberg, E.W., Rampen, A.J., Farace, E., Habbema, J.D., Marshall, L.F., Murray, G.D., and Maas, A.I. (2003). Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J. Neurosurg. 994, 666-673.
26. Ingebrigtsen, T., and Romner, B. (2002). Biochemical serum markers of TBI. J. Trauma 52, 798-808.
27. Jennett, B. (1975). Predicting outcome after head injury. J R Coll Physicians Land. 9, 231-237.
28. Jennett, B., and Teasdale, G. (1977). Aspects of coma after severe head injury. Lancet 1, 878-881.
29. Johnson, A.M., Rohlfs, E.M., and Silverman, L.N. (1999). Proteins, in: Tietz Textbook of Clinical Chemistry. C.A. Burtis, and E.R. Ashwood (eds), W.B. Saunders Company: Philadelphia, p. 516.
30. Johnsson P. (1996). Markers of cerebral ischemia after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 10, 120-126.
31. Kesler, E.A. (2000). SPECT, MR and quantitative MR imaging: correlates with neuropsychological and psychological outcomes in traumatic brain injury. Brain Inj. 14, 851-857.
32. Kmietowicz, Z. (2007). Better safe than sorry? BMJ 335, 1182-1184.
33. Levi, E.A. (1990). Diffuse axonal injury: Analysis of 100 patients with radiological signs. Neurosurgery 27, 429-432.
34. Levin, H.S., Saydjari, C., Eisenberg, H.M., Foulkes, M., Marshall, L.F., Ruff, R.M., Jane, J.A., and Marmarou, A. (1991). Vegetative state after closed-head injury. A Traumatic Coma Data Bank Report. Arch Neurol 48, 580-585.
35. Lewis, S.B., Velat, G.J., Miralia, L., Papa, L., Aikman, J.M., Wolper, R.A., Firment, C.S., Liu, M.C., Pineda, J.A., Wang, K.K., and Hayes, R.L. (2007). Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury. J. Neurosurg. 1074, 792-796.
36. Lyeth, B.G., Jiang, J.Y., Robinson, S.E., Guo, H., and Jenkins, L.W. (1993). Hypothermia blunts acetylcholine increase in CSF of traumatically brain injured rats. Mol. Chem. Neuropathol. 18, 247-256.
37. Maas, A.I., Hukkelhoven, C.W., Marshall, L.F., and Steyerberg, E.W. (2005). Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery 57, 1173-1182.
38. Marangos, P.J., and Schmechel, D.E. (1987). Neuron specific enolase, a clinically useful marker for neurons and neuroen-docrine cells. Ann. Rev. Neurosci. 10, 269-295.
39. Marion, D.W. (1996). Outcome from severe head injury, in: Neurotrauma. R.K. Narayan, E. Wilberger, and J.T. Povlishock (eds). McGraw Hill: New York, pps. 767-777.
40. Marmarou, A., Lu, J., Butcher, I., McHugh, G.S., Murray, G.D., Steyerberg, E.W., Mushkudiani, N.A., Choi, S., and Maas, A.I. (2007). Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis. J. Neurotrauma 242, 270-280.
41. Marshall, L.F., Marshall, S.B., and Klauber, M.R. (1991). A new classification of head injury based on computerized tomography. J. Neurosurg. 75 (Suppl.), S14-S20.
42. Maxwell, W.L., Povlishock, J.T., and Graham, D.I. (1997). A mechanistic analysis of non-disruptive axonal injury: a review. J. Neurotrauma 14, 419-439.
43. McCracken, E., Hunter, A.J., Patel, S., Graham, D.I., and Dewar, D. (1999). Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J. Neurotrauma 169, 749-761.
44. McGinn, M.J., Kelley, B.J., Akinyi, L., Oli, M.W., Liu, M.C., Hayes, R.L., Wang, K.K., Povlishock, J.T. (2009) Biochemical, structural, and biomarker evidence for calpain-mediated cy-toskeletal change after diffuse brain injury uncomplicated by contusion. J. Neuropathol. Exp. Neurol. 68, 241-249.
45. McKeating, E.G., Andrews, P.J.D., and Mascia, L. (1998). Relationship of neuron specific enolase and protein S-100 concentrations in systematic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neu-rochir. Suppl. Wien. 71, 117-119. (Pubitemid 128444374)
46. Mushkudiani, N.A., Engel, D.C., Steyerberg, E.W., Butcher, I., Lu, J., Marmarou, A., Slieker, F., McHugh, G.S., Murray, G.D., and Maas, A.I. (2007). Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study. J Neurotrauma 242, 259-269. (Pubitemid 46492147)
47. Narayan, R.K., Greenberg, R.P., Miller, J.D., Enas, G.G., Choi, S.C., Kishore, P.R., Selhorst, J.B., Lutz, H.A. 3rd, and Becker, D.P. (1981). Improved confidence of outcome prediction in severe head injury. A comparative analysis of the clinical examination, multimodality evoked potentials, CT scanning, and intracranial pressure. J. Neurosurg. 54, 751-762.
48. Newcomb, J.K., Kampfl, A., Posmantur, R.M., Zhao, X., Pike, B.R., Liu, S.J., Clifton, G.L., and Hayes, R.L. (1997). Im-munohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. J. Neurotrauma 14, 369-383.
49. Palfreyman, J.W., Thomas, D.G.T., and Ratcliffe, J.G. (1978). Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury. Clin. Chim. Acta. 82, 259-270.
50. Papa, L., Akinyi, L., Liu, M.C., Pineda, J.A., Tepas, J.J. 3rd, Oli, M.W., Zheng, W., Robinson, G., Robicsek, S.A., Gabrielli, A., Heaton, S.C., Hannay, H.J., Demery, J.A., Brophy, G.M., Layon, J., Robertson, C.S., Hayes, R.L., and Wang, K.K. (2009). Ubi-quitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care. Med. 38, 138-144.
51. Papa, L., Robinson, G., Oli, M., Pineda, J., Demery, J., Brophy, G., Robicsek, S.A., Gabrielli, A., Robertson, C.S., Wang, K.K., and Hayes, R.L. (2008). Use of biomarkers for diagnosis and
52. Pike, B.R., Flint, J., Dutta, S., Johnson, E., Wang, K.K., and Hayes, R.L. (2001). Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 786, 1297-1306.
53. Pike, B.R., Flint, J., Dave, J.R., Lu, X.C., Wang, K.K., Tortella, F.C., and Hayes, R.L. (2004). Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alpha II-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 24, 98-106.
54. Pineda, J.A., Lewis, S.B., Valadka, A.B., Papa, L., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Aikman, J.M., Akle, V., Brophy, G.M., Tepas, J.J., Wang, K.K., Robertson, C.S., Hayes, R.L. (2007). Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
55. Povlishock, J.T., and Christman, C.W.J. (1995). The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. Neurotrauma 124, 555-564.
56. Raabe, A., and Seifert, V. (1999). Fatal secondary increase in serum S-100B protein after severe head injury. J. Neurosurg. 91, 875-877.
57. Raabe, A., Grolms, C., and Seifert, V. (1999a). Serum markers of brain damage and outcome prediction in patients after severe head injury. Br. J. Neurosurg. 13, 56-59.
58. Raabe, A., Grolms, C., Sorge, O., Zimmermann, M., and Seifert, V. (1999b). Serum S-100B protein in severe head injury. J. Neurosurg. 45, 477-483.
59. Raabe, A., Menon, D.K., Gupta, S., Czosnyka, M., and Pickard, J.D. (1998). Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J. Neurol. Neurosurg. Psychiatry 65, 930-932.
60. Riederer, B.M., Zagon, I.S., and Goodman, S.R. (1986). Brain spectrin 240/235 and brain spectrin 240/235E: two distinct spectrin subtypes with different locations within mammalian neural cells. J. Cell Biol. 102, 2088-2097.
61. Ringger, N.C., O'Steen, B.E., Brabham, J.G., Silver, X., Pineda, J., Wang, K.K., Hayes, R.L., and Papa, L. (2004). A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J. Neurotrauma 21, 1443-1456.
62. Robertson, R.L., Robson, C.D., Zurakowski, D., Antiles, S., Strauss, K., and Mulkern, R.V. (2003). CT versus MR in neonatal brain imaging at term. Pediatr. Radiol. 337, 442-449.
63. Romner, B., and Ingebrigtsen, T. (2001). High serum S100B levels for trauma patients without head injuries. J. Neurosurg. 49, 1490.
64. Romner, B., Ingebrigtsen, T., Kongstad, P., and Borgesen, S.E. (2000). Traumatic brain injury: serum S-100 measurements related to neuroradiological findings. J. Neurotrauma 17, 641-647.
65. Ross, S.A., Cunningham, R.T., Johnston, C.F., and Rowlands, B.J. (1996). Neuron-specific enolase as an aid to outcome prediction in head injury. Br. J. Neurosurg. 10, 471-476.
66. Rothoerl, R.D., and Woertgen, C. (2001). High serum S100B levels for trauma patients without head injuries. J. Neurosurg. 49, 1490-1491.
67. Rowley, G., and Fielding, K. (1991). Reliability and accuracy of the Glasgow Coma Scale with experienced and inexperienced users. Lancet 337, 535-538.
68. Saatman, K.E., Abai, B., Grosvenor, A., Vorwerk, C.K., Smith, D.H., and Meaney, D.F. (2003) Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice. J. Cereb. Blood Flow Metab. 23, 34-42.
69. Saatman, K.E., Bozyczko-Coyne, D., Marcy, V., Siman, R., and McIntosh, T.K. (1996). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860.
70. Serbest, G., Burkhardt, M.F., Siman, R., Raghupathi, R., and Saatman, K.E. (2007). Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem. Res. 32, 2006-2014.
71. Servadei, F., Murray, G.D., Penny, K., Teasdale, G.M., Dearden, M., Iannotti, F., Lapierre, F., Maas, A.J., Karimi, A., Ohman, J., Persson, L., Stocchetti, N., Trojanowski, T., and Unterberg, A. (2000). The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury. European Brain Injury Consortium [discussion 75-77]. J. Neuro-surg. 46, 70-75.
72. Sosin, D.M., Sniezek, J.E., and Thurman, D.J. (1996). Incidence of mild and moderate brain injury in the United States. Brain Inj. 10, 47-54.
73. Stein, S.C. (1996). Classification of head injury, in: Neurotrauma. R.K. Narayan, E. Wilberger, and J.T. Povlishock (eds), McGraw-Hill: New York, pps. 31-41.
74. Stocchetti, N., Pagan, F., Calappi, E., Canavesi, K., Beretta, L., Citerio, G., Cormio, M., and Colombo, A. (2004). Inaccurate early assessment of neurological severity in head injury. J. Neurotrauma 21, 1131-1140.
75. Teasdale, G., and Jennett, B. (1976). Assessment and prognosis of coma after head injury. Acta Neurochir. Wien. 34, 45-55.
76. Teasdale, G., and Jennett, B. (1974). Assessment of coma and impaired consciousness. A practical scale. Lancet 2, 81-84.
77. Thomas, D.G., Palfreyman, J.W., and Ratcliffe, J.G. (1978). Serum myelin basic protein assay in diagnosis and prognosis of patients with head injury. Lancet 21, 113-115.
78. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Snie-zek, J.E. (1998). Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 14, 602-615.
79. Wang, K.K., Ottens, A.K., Liu, M.C., Lewis, S.B., Meegan, C., Oli, M.W., Tortella, F.C., and Hayes, R.L. (2005). Proteomic identification of biomarkers of traumatic brain injury. Expert Rev. Proteomics 24, 603-614.
80. Wang, K.K., Posmantur, R., Nath, R., McGinnis, K., Whitton, M., Talanian, R.V., Glantz, S.B., and Morrow, J.S. (1998). Simultaneous degradation of alphaII-and betaII-spectrin by caspase 3 CPP32 in apoptotic cells. J. Biol. Chem. 273, 22490-22497.
81. Wang, K.K.W. (2000). Calpain and caspase: Can you tell the difference. Trends Neurosci. 23, 20-26.
82. Woertgen, C., Rothoerl, R.D., Holzschuh, M., Metz, C., and Brawanski, A. (1997). Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neu-rochir. Wien. 139, 1161-1165.
83. Woertgen, C., Rothoerl, R.D., Metz, C., and Brawanski, A. (1999). Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J. Trauma 47, 1126-1130.
84. Xiong, H., Liang, W.L., and Wu, X.R. (2000). [Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]. Sheng Li Ke Xue Jin Zhan 31, 217-221.